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S U M M A R Y
Objectives: Neurogenic pulmonary edema (NPE) is a fatal complication in children with enterovirus 71
(EV71) encephalitis. Endothelin 1 (ET-1), a potent vasoconstrictor, can induce pulmonary edema in rats
via intrathecal injections. Thus, it was hypothesized that ET-1 in the central nervous system may
correlate with NPE in children with EV71 encephalitis.
Methods: Clinical data and ET-1 in the cerebrospinal ﬂuid (CSF) were compared between three groups:
(1) EV71 encephalitis with NPE; (2) EV71 encephalitis without NPE; and (3) non-EV71 aseptic
meningitis. ET-1 immunostaining was performed on the brainstem of autopsy patients.
Results: The EV71 with NPE group showed signiﬁcantly increased CSF levels of ET-1 compared to the
EV71 without NPE and the non-EV71 aseptic meningitis groups (both p < 0.01). The optimum cut-off
point of ET-1 to predict NPE in EV71 patients, based on the receiver operating characteristic curve, was
0.5 pg/ml (sensitivity 83%, speciﬁcity 100%). Immunostaining in the brainstem showed increased ET-1
expression, mainly in the oligodendrocytes, in EV71 with NPE patients compared with control patients.
Conclusion: ET-1 in the central nervous system may play a role in the development of NPE in children
with EV71 infection and could be used as a biomarker or therapeutic target for NPE in EV71 encephalitis.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Enterovirus 71 (EV71) belongs to the human Enterovirus A
species within the family Picornaviridae. EV71 is a frequent cause of
hand, foot and mouth disease, which can be complicated by severe
neurological involvement in children, especially those younger
than 5 years of age.1 Most of the fatal cases initially present with
minor neurological symptoms, rapidly become complicated with
autonomic neurological dysfunction and neurogenic pulmonary
edema (NPE), and die of cardiopulmonary failure soon after
admission. The mortality from this condition ranges from 80% to* Corresponding author. Tel.: +886-6-235-3535 ext. 5273; fax: +886-6-275-3083.
E-mail address: nckutu@gmail.com (Y.-F. Tu).
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1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).90%.1 The presence of NPE is usually the main cause of fatal EV71
during epidemics, but its pathogenesis is not completely under-
stood. Brain magnetic resonance imaging (MRI) studies have
shown a propensity of EV71 infection for the tegmentum of the
pons and medulla oblongata. Post-mortem studies have demon-
strated that patients who died from EV71-induced NPE had acute
inﬂammation and EV71 antigens within neurons in the brain-
stem.2,3 Thus, brainstem encephalitis is speculated to be the cause
of acute fatality with NPE after EV71 infection.4
Endothelin 1 (ET-1), a 21-amino acid peptide, is a potent
vasoconstrictor.5 Because its mRNA and receptor binding sites are
expressed in several regions of the brain, ET-1 can also work as a
neurotransmitter to regulate neurological functions. 6,7 Several
animal studies have shown that intrathecal injection of ET-1 elicits
a transient increase in arterial blood pressure, heart rate, andciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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enhances pulmonary vascular permeability and causes pulmonary
edema.7 It was concluded that pulmonary edema was due to
intense pulmonary vasoconstriction mediated by a-adrenoceptors
following the release of catecholamines in response to the
activation of endothelin receptors in the central nervous system.7
Thus, ET-1 plays a role in inducing NPE.
It was hypothesized that the occurrence of NPE in children with
EV71 infection is correlated with an increase in ET-1 in the
brainstem. Cerebrospinal ﬂuid (CSF) samples and autopsy brain
specimens from patients with EV71 infection were used to
investigate this issue.
2. Materials and methods
2.1. Patients
The cases of 16 patients with EV71 encephalitis who had been
admitted to the study hospital during the EV71 epidemic from
1998 to 2000 in southern Taiwan were reviewed. The inclusion
criteria for the patients with EV71 encephalitis were the following:
(1) deﬁned EV71 infection by viral isolation, (2) presence of
neurological manifestations including headache, altered con-
sciousness, myoclonic jerks, ataxia, tremor, acute ﬂaccid paralysis,
bulbar palsy, or NPE, and (3) CSF leukocyte count >10  106 cells/
l.1 NPE was deﬁned as the occurrence of respiratory distress,
tachycardia, tachypnea, and copious frothy sputum, with chest
radiological ﬁndings of bilateral pulmonary inﬁltrates without
cardiomegaly. The 16 patients who had EV71 encephalitis were
further stratiﬁed into two groups: EV71 encephalitis without NPE
(n = 10) and EV71 encephalitis with NPE (n = 6).
An additional control group comprised nine patients with non-
EV71 aseptic meningitis who were admitted during the same
period. The diagnosis of non-EV71 aseptic meningitis was based on
the following criteria: (1) CSF leukocyte count >10  106 cells/l
with a predominance of mononuclear cells, (2) negative bacterial
studies, including CSF and blood cultures, and (3) self-limited
clinical course without clinical evidence of encephalopathy, such as
seizures, disturbances of consciousness, or focal neurological signs.
All of the medical charts, laboratory results, and MRI scans were
reviewed retrospectively. The study was approved by the
institutional review board of the National Cheng Kung University
Hospital.
2.2. Virology studies
EV71 was conﬁrmed by virus isolation as described previously.1
Brieﬂy, specimens were inoculated onto monolayers of A549, Vero,
and green monkey kidney cells within 24 h and then incubated and
evaluated for evidence of a viral cytopathic effect. Isolates were
further typed using an immunoﬂuorescence assay with EV71
monoclonal antibodies 3323 and 3324 (Chemicon International,
Temecula, CA, USA). EV71 was identiﬁed by positive staining of
both antibodies. These isolates were further conﬁrmed by
neutralization testing using polyclonal antiserum (American Type
Culture Collection, Rockville, MD, USA).
2.3. Analysis of ET-1
Archived CSF specimens had been stored in cryogenic vials in
80 8C freezers; these specimens had been placed in the freezers
within 4–6 h after collection. ET-1 concentrations were deter-
mined using the QuantiGlo Human ET-1 Chemiluminescent
Immunoassay (R&D Systems, Minneapolis, MN, USA). According
to the manufacturer, the sensitivity of the ET-1 assay is
0.102 pg/ml. In brief, a monoclonal antibody speciﬁc for ET-1was pre-coated onto a microplate to bind ET-1 in standards and
samples. After washing, an enzyme-linked monoclonal antibody
speciﬁc for ET-1 was added to the wells. Following a wash, an
enhanced luminol/hydrogen peroxide substrate solution was
added and light was produced in proportion to the amount of
ET-1 bound in the initial step. A microplate luminometer
(Luminoskan Ascent; Thermo Scientiﬁc, Waltham, MA, USA) was
used to measure the intensity of the light emitted. The standard
curve was modiﬁed from the R&D Systems recommendations to
include 0.04, 0.2, 1, and 5 pg/ml standards. Raw data were
transferred to a computer in which a log concentration–log RLU
(relative light unit) equation was deﬁned and sample concen-
trations were calculated.
2.4. Immunohistochemistry and double-immunoﬂuorescence
staining
ET-1 immunohistochemistry was performed on selected blocks
of nervous tissue from a patient who had died in the EV71
encephalitis with NPE group. To compare the differences in ET-1
expression in the brainstem, another age-matched patient who
had died of severe neuroblastoma without brainstem metastasis
was used as a control. Tissue sections (10 mm in thickness) were
deparafﬁnized with xylene and graded ethanol solutions. The
antigen was retrieved by microwaving for 10 min in sodium citrate
buffer, pH 6.0. For immunohistochemistry, tissue sections were
blocked with 2% normal goat serum and 0.1% Triton X-100, and
probed with primary antibodies to ET-1 (1:200, Abcam) at 4 8C
overnight, followed by a 2-h incubation with horseradish
peroxidase (HRP)-conjugated anti-mouse secondary antibodies
at room temperature. Biotin-peroxidase signals were detected
using 0.5 mg/ml 3,30-diaminobenzidine/0.003% H2O2 as a sub-
strate. For double-immunoﬂuorescence staining, tissue sections
were probed with primary antibodies anti-microtubular-associat-
ed protein 2 (MAP-2) (1:50, Cell Signaling), anti-CD68 (1:50, Santa
Cruz), anti-Iba1 (1:500, Wako), anti-glial ﬁbrillary acidic protein
(GFAP) (1:500, Abcam), anti-Oligo2 (1:500, Abcam), or anti-ET-1
(1:200, Abcam) at 4 8C overnight after blocking. The sections were
then incubated with Alexa Fluor 488 goat IgG and Alexa Fluor
594 goat IgG secondary antibodies (Invitrogen, Carlsbad, CA, USA)
for 1 h at room temperature after washing. Images were acquired
on a Nikon E400 ﬂuorescence microscope (Tokyo, Japan). Digitally
captured images were analyzed using Imaging Software NIS-
Elements (Nikon, Tokyo, Japan).
2.5. Statistical analysis
Signiﬁcant differences between the study groups were assessed
using a commercial software program (SPSS version 17.0; SPSS Inc.,
Chicago, IL, USA). One of the authors (CHL), who was blinded to the
study design, performed all the statistical analyses. Continuous
data are presented as the mean  standard deviation (SD) and were
tested by non-parametric Mann–Whitney U-test. Categorical vari-
ables were tested by Chi-square test or Fisher’s exact test. A receiver
operating characteristic (ROC) curve was constructed to assess the
sensitivity and speciﬁcity of ET-1. A p-value of <0.05 was considered
statistically signiﬁcant, and all probabilities were two-tailed.
3. Results
3.1. Study patients
The demographic information and clinical manifestations of the
three groups are shown in Table 1. Although the EV71 encephalitis
with NPE group was younger at disease onset, the age at onset was
comparable between the three groups. On admission, the EV71
Table 1
Demographic and clinical ﬁndings of the three groups of patientsa
EV71 encephalitis with NPE
(n = 6)
EV71 encephalitis without NPE
(n = 10)
Non-EV71 aseptic meningitis
(n = 9)
p-Valueb p-Valuec
Age, months 24.2  17.2 39.2  32.2 53  75.4 NS NS
Male/female, n/n 4/2 6/4 5/4 NS NS
Vital signs at admission
Body temperature, 8C 37.7  0.6 37.8  0.5 37.9  1.3 NS NS
Heart rate, /min 163  21 131  15 110  26 0.01 0.006
Arterial BP, mmHg
Systolic 132  8 114  15 112  10 0.037 0.027
Diastolic 77  12 72  18 84  42 NS NS
Respiratory rate, /min 42  14 28  8 33  13 0.019 NS
Neurological symptom/signs, n (%)
Altered consciousness 5 (83.3%) 0 (0%) 0 (0%) 0.001 0.002
Limb paralysis 3 (50%) 0 (0%) 0 (0%) 0.036 0.044
Myoclonus 3 (50%) 10 (100%) 0 (0%) 0.036 0.044
Ataxia/tremor 2 (33.3%) 1 (10%) 0 (0%) NS NS
Bulbar involvement 2 (33.3%) 0 (0%) 0 (0%) NS NS
Seizure 2 (33.3%) 0 (0%) 0 (0%) NS NS
Headache 1 (16.7%) 2 (20%) 4 (44.4%) NS NS
Admission course
Dopamine, n (%)/days 4 (66.7%)/1.8  0.5 0 (0%)/0 0 (0%)/0 0.008 0.008
Dobutamine, n (%)/days 4 (66.7%)/2.8  0.9 0 (0%)/0 0 (0%)/0 0.008 0.008
Intubation, n (%)/days 6 (100%)/2.2  1.2 0 (0%)/0 0 (0%)/0 <0.001 <0.001
Outcome, n (%)
Death 1 (16.7%) 0 (0%) 0 (0%) NS NS
Neurological sequelae 3/5 (60%) 0 (0%) 0 (0%) 0.022 0.027
BP, blood pressure; EV71, enterovirus 71; NPE, neurogenic pulmonary edema; NS, not signiﬁcant.
a Results are presented as the mean  standard deviation, unless stated otherwise.
b p-Values for comparisons between the EV71 with NPE and EV71 without NPE groups.
c p-Values for comparisons between the EV71 with NPE and non-EV71 aseptic meningitis groups.
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arterial blood pressures than the EV71 without NPE group and the
non-EV71 aseptic meningitis group (all p < 0.05). The most
common neurological manifestation was altered consciousness
in EV71 with NPE patients, myoclonus in patients with EV71
without NPE, and headaches in patients with non-EV71 aseptic
meningitis.
3.2. Clinical course and outcome
All of the patients with EV71 and NPE had respiratory failure
that required intubation for oxygen and respiratory support, and
most were also treated with inotropic agents such as dopamine/
dobutamine for hypotension or shock. None of the patients with
EV71 without NPE or the non-EV71 patients with aseptic
meningitis had respiratory failure or hypotension (Table 1). In
the EV71 with NPE group, one patient died due to cardiopulmonary
failure and three patients had persistent limb paralysis on follow-
up. None of the patients in the EV71 without NPE group or in the
non-EV71 aseptic meningitis group had abnormal neurological
outcomes.Table 2
CSF dataa
EV71 encephalitis with NPE
(n = 6)
EV71 encephalit
(n = 10)
WBC, 106 cells/l 126  127 103  175 
Segmented neutrophils (%) 34  40 70  29 
Lymphocytes (%) 36  42 18  18 
Lactate, mM/l 3.2  3.9 1.4  0.5 
Protein, mg/dl 57  27 40  21 
Glucose, mg/dl 72  8 64  10 
CSF, cerebrospinal ﬂuid; EV71, enterovirus 71; NPE, neurogenic pulmonary edema; NS
a Results are presented as the mean  standard deviation.
b p-Values for comparisons between EV71 with NPE and EV71 without NPE groups.
c p-Values for comparisons between EV71 with NPE and non-EV71 aseptic meningit3.3. CSF ET-1 levels
Total white blood cell counts in the CSF of the three groups were
similar. A slight predominance of CSF mononuclear cells in the
patients with non-EV71 aseptic meningitis compared with patients
in the EV71 with and without NPE groups was noted (Table 2). The
patients in the EV71 with NPE group had signiﬁcantly higher CSF
levels of ET-1 (mean  SD, 0.56  0.09 pg/ml) than the patients in the
EV71 without NPE group (0.32  0.14 pg/ml; p < 0.002) and the
patients in the non-EV71 aseptic meningitis group (0.22  0.14 pg/ml;
p < 0.004) (Figure 1A). CSF levels of ET-1 were similar in the EV71
without NPE and the non-EV71 with aseptic meningitis groups. The
area under the ROC curve of ET-1 for the diagnosis of NPE in EV71-
infected patients was 0.967 (Figure 1B). The best cut-off point was
0.5 pg/ml, with a sensitivity of 83% (95% conﬁdence interval 36.5% to
99.1%) and speciﬁcity of 100% (95% conﬁdence interval 65.5% to 100%).
3.4. Brainstem lesions and ET-1 expression
MRI was available for four patients in the EV71 with NPE group.
Three patients showed high T2 signal lesions in the dorsal medullais without NPE Non-EV71 aseptic meningitis
(n = 9)
p-Valueb p-Valuec
68  66 NS NS
7  10 NS NS
69  29 NS 0.05
1.4  0.3 NS NS
59  27 NS NS
58  13 NS NS
, not signiﬁcant; WBC, white blood cell count.
is groups.
Figure 1. ET-1 values in the CSF. (A) The EV71 encephalitis with NPE group had signiﬁcantly higher CSF levels of ET-1 than the EV71 encephalitis without NPE group and the
non-EV71 with aseptic meningitis group; *p-value = 0.005, **p-value = 0.004. (B) ROC curve of CSF ET-1 levels for the diagnosis of NPE caused by EV71 infection.
(Abbreviations: ET-1, endothelin 1; CSF, cerebrospinal ﬂuid; EV71, enterovirus 71; NPE, neurogenic pulmonary edema; ROC, receiver operating characteristic.)
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and two also had a longitudinal high T2 signal lesion at the spinal
cord. The MRI of the patient who died of EV71 infection with NPE
showed T2 hyperintensity lesions at the pontine tegmentum and
dorsal medulla oblongata (Figure 2A). ET-1 immunohistochemistry
in the medulla oblongata of this patient showed increased cellular
ET-1 expression compared with a patient with a high-grade
neuroblastoma without brain metastasis (Figure 2B). Immuno-
ﬂuorescence showed that the upregulated expression of ET-1 did
not co-express in MAP-2-positive neurons, CD68-positive macro-
phages, Ib1-positive microglia, or GFAP-positive astrocytes.
Instead, ET-1 was mainly co-localized with the Oligo2-positive
oligodendrocytes (Figure 3).
4. Discussion
Since its ﬁrst discovery in 1969, EV71 has caused several major
epidemics of hand, foot and mouth disease complicated with
severe neurological sequelae throughout the world.4,9 In the
1998 Taiwan outbreak, 1.5 million people were infected, more than
400 children were admitted with neurological complications, and
up to 78 children died of complications, such as NPE and
cardiopulmonary failure.10 Even though several pathogenic
mechanisms of NPE after EV71 infection have been proposed,
the exact mechanism remains unclear.4 The present study
provided clinical evidence that EV71-infected patients with NPE
had increased ET-1 in the CSF compared to EV71-infected patients
without NPE and non-EV71 patients with aseptic meningitis.
Immunohistochemistry also conﬁrmed increased ET-1 expression
in the medulla oblongata of a patient with fatal EV71 infection and
NPE. Interestingly, ET-1 was expressed mainly in oligodendrocytes
instead of neurons, macrophages, microglia, or astrocytes. These
ﬁndings suggest that ET-1 produced by oligodendrocytes may play
a role in the development of NPE in EV71-induced brainstem
encephalitis.
NPE is characterized by dyspnea, bilateral basal pulmonary
crackles, and the absence of cardiac failure.11 NPE usually occurs
within minutes to hours after a central neurological insult that
causes damage to potential NPE trigger zones in the brainstem,
especially the vasomotor centers in the medulla oblongata and
hypothalamus, and leads to massive sympathetic discharges.12,13
The signiﬁcant alterations in the autonomic nervous system in turn
increase lung capillary permeability or pulmonary vascularhydrostatic pressures, and cause pulmonary edema.14,15 Animal
experiments have shown that damage to the medulla oblongata
can produce profound transient pulmonary and systemic hyper-
tension and pulmonary edema.16–18 These responses can be
abolished by a-adrenergic blockade (with phentolamine) or spinal
cord transection at the C7 level.13,17 Thus, NPE may be caused by
damage to the medulla oblongata through activating sympathetic
tone.
Clinically, most children with EV71 encephalitis with NPE have
had preceding sympathetic symptoms, such as tachycardia,
tachypnea, and hypertension, before the onset of clinical deterio-
ration.10,19 Manifestations of cardiopulmonary failure, including
hypotension and pulmonary edema, follow rapidly within hours.20
Some patients have died soon after the deterioration. Neuroimag-
ing and neuropathological studies have conﬁrmed EV71-induced
damage to the brainstem, where EV71 antigens, virus-like
particles, and inﬂammation were found.1,2,19,21 These clinical
manifestations and pathological ﬁndings suggest that EV71 causes
inﬂammation of the NPE trigger zone in the brainstem, over-
activates sympathetic tone, and results in the development of NPE.
ET-1 is known to be a potent vasoconstrictor.5 Animal studies
have shown that intracerebroventricular injection of ET-1
(10 pmol) increases arterial blood pressure, heart rate, and
sympathetic nerve activity.8,22 Intracisternal administration of a
higher dose of ET-1 (20 pmol) has been shown to result in
hypotension, bradycardia, and 100% mortality.23 Moreover,
intrathecal ET-1 (650 pmol) has been shown to enhance pulmo-
nary vascular permeability and cause pulmonary edema.7 These
changes induced by increasing doses of central ET-1 injection are
quite similar to the progression of clinical symptoms in patients
with EV71-induced NPE. In the brainstem, endothelin binding sites
have been found in the vasomotor centers, including the nucleus of
the solitary tract and rostroventrolateral medulla, which partici-
pates in cardiovascular function.24,25 Thus, endogenous ET-1
induced by EV71 in the brainstem may elicit sympathetic tone
through stimulation of vasomotor centers, enhance pulmonary
vascular permeability, and lead to NPE. This concept is supported
by the ﬁndings of the present study in which EV71-infected
patients with NPE had increased ET-1 levels in the CSF and cellular
ET-1 expression in the medulla oblongata. Taken together, ET-1
may be involved in the induction of NPE during EV71 infection, and
CSF ET-1 could be a sensitive biomarker of NPE in patients with
EV71 infection.
Figure 2. MRI and ET-1 immunohistochemistry in the brainstem of autopsy patients. (A) T2-weighted MRI (TR 3500 ms, TE 93 ms) showing hyperintense signals in the dorsal
pons and medulla oblongata in a patient with EV71 encephalitis with NPE. (B) ET-1 immunohistochemistry revealed that a patient who died of EV71 encephalitis and NPE had
increased intracellular ET-1 expression in the dorsal medulla oblongata (upper panel) compared to a control patient who died of neuroblastoma without brain metastasis
(lower panel). ET-1-positive cells are brown in color and one is marked with an arrow (upper panel). Scale bar = 50 mm. (Abbreviations: MRI, magnetic resonance imaging; ET-
1, endothelin 1; TR, repetition time; TE, echo time; EV71, enterovirus 71; NPE, neurogenic pulmonary edema.)
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immune-relevant proteins and respond speciﬁcally to immuno-
logical exposures in various pathological situations.26 For example,
oligodendrocytes and their progenitor cells express interleukin
(IL)-1b and its receptors during development, and IL-18 and its
receptors in cases of white matter injury.27,28 Thus, oligoden-
drocytes like microglia can be involved in the immune reactions to
the central nervous system infection. In this study, it was found
that the majority of ET-1-positive cells were Oligo2-positive
oligodendrocytes. These data indicate that oligodendrocytes are
the major cell origin that produces ET-1 in patients with NPE
during EV71 infection. Although ET-1 can stimulate microglia
lineage cells to express inﬂammatory cytokines, CSF cytokine
changes have been shown not to be associated with EV71 clinical
severity or outcomes.29–31 Thus, ET-1 may function as a stimulatorto increase sympathetic activity instead of inducing inﬂammatory
responses in the brain.22
In accordance with the present ﬁndings, it is hypothesized that
EV-71 infection triggers oligodendrocytes to produce ET-1, which
increases sympathetic activity initially through stimulation of
vasomotor centers in the brainstem. The increased amount of ET-1
results in hypotension, bradycardia, and pulmonary edema.
Further prospective studies involving a large population with
EV71 infection are needed in order to validate these ﬁndings. The
correlated ET-1 expression in serum or respiratory secretions could
be investigated as well. There are two US Food and Drug
Administration (FDA)-approved ET-1 antagonists – bosentan and
ambrisentan – which have been used clinically in pulmonary
artery hypertension patients. If a causal relationship between ET-1
and NPE pathogenesis is established in further studies, ET-1
Figure 3. Immunoﬂuorescence staining in the patient with fatal EV71 infection and NPE. Immunoﬂuorescence staining in the patient with fatal EV71 infection and NPE
showed that ET-1 was not expressed in neurons (MAP-2), macrophages (CD68), microglia (Ib1), or astrocytes (GFAP). Most ET-1 was co-localized with oligodendrocytes
(Oligo2). Scale bar = 100 mm. High magniﬁcation images are shown in the inserts (scale bar = 50 mm). (Abbreviations: EV71, enterovirus 71; NPE, neurogenic pulmonary
edema; ET-1, endothelin 1.)
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complicated with NPE.
This study provides the ﬁrst evidence that CSF ET-1 is increased
in patients with EV71-induced NPE. Because NPE is the leading fatal
complication in children infected by EV71, early detection of NPE
occurrence is critical. ET-1 could also be a potential therapeutic
target for preventing or treating NPE in EV71 encephalitis.
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